Skip to main content

COVID-19-associated rhino-orbital mucormycosis (CAROM)—a case report



There has been a rapid rise in the number of COVID-19-associated rhino-orbital mucormycosis (CAROM) cases especially in South Asian countries, to an extent that it has been considered an epidemic among the COVID-19 patients in India. As of May 13, 2021, 101 CAROM cases have been reported, of which 82 cases were from India and 19 from the rest of the world. On the other hand, pulmonary mucormycosis associated with COVID-19 has a much lesser reported incidence of only 7% of the total COVID-19-associated mucormycosis cases (Singh AK, Singh R, Joshi SR, Misra A, Diab Metab Syndr: Clin Res Rev, 2021). This case report attempts to familiarize the health care professionals and radiologists with the imaging findings that should alarm for follow-up and treatment in the lines of CAROM.

Case presentation

Rhino-orbital mucormycosis (ROM) is a manifestation of mucormycosis that is thought to be acquired by inhalation of fungal spores into the paranasal sinuses. Here, we describe a 55-year-old male, post COVID-19 status with long standing diabetes who received steroids and ventilator therapy for the management of the viral infection. Post discharge from the COVID-19 isolation ICU, the patient complained of grayish discharge from the right nostril and was readmitted to the hospital for the nasal discharge. After thorough radiological and pathological investigation, the patient was diagnosed with CAROM and managed.


Uncontrolled diabetes and imprudent use of steroids are both contributing factors in the increased number of CAROM cases. Our report emphasizes on the radiological aspect of CAROM and reinforces the importance of follow-up imaging in post COVID-19 infection cases with a strong suspicion of opportunistic infections.


Mucormycosis is an opportunistic angioinvasive disease caused by organisms in the order Mucorales [1]. These organisms are present universally in nature; however, in the background of COVID-19 infection has a high mortality of 30.7% [2]. Prior to the COVID-19 pandemic, the prevalence of mucormycosis in India was approximately 0.14 cases per 1000 population, about 80 times the prevalence in developed countries [3, 4]. With the ongoing second wave of the COVID-19 pandemic, there has been a tremendous increase in the number of ROM cases. Some patients have no option other than debridement surgeries (including enucleation) leaving a substantial percentage of them blind. Here, the role of the radiologist is important to flag such a case and report it early to the treating physician. The most common risk factor in India associated with mucormycosis is diabetes mellitus [5]. To the best of our knowledge, this is the first case report of CAROM from Eastern India.

Case presentation

The 55-year-old male was admitted in the COVID-19 ICU for a period of 2 weeks and treated according to the existing protocols, including steroids and ventilator therapy. On the second day after discharge from the ICU, the patient developed loss of sensation in the skin overlying the malar area with periorbital pain and nasal stuffiness. The next day, he complained of grayish discharge from the right nostril for which he was readmitted in the hospital. The oral examination revealed white crusting over right hard palate (Fig. 1), a finding which was perhaps not appreciated during the first admission. Subsequently, the patient was sent to our department for imaging. A diagnosis of CAROM was established after magnetic resonance imaging (MRI), computed tomography (CT) scan, and microbiological confirmation in a background of COVID-19 infection.

Fig. 1
figure 1

Swelling of the right periorbital area with a plaque-like grayish lesion in the right palate

He was a known case of diabetes mellitus type 2 on treatment with human actrapid for 20 years. With HbA1C being 10.7% mg/dl, Inter Leukin-6 being 12 pg/ml, fasting plasma glucose at 182 mg/dl at admission. The coronavirus infection was determined by reverse transcription–polymerase chain reaction (RT-PCR) assays on throat swab samples using a TRUPCR SARS-CoV-2 RT quantitative PCR Kit (in DNA Life Sciences Pvt. Ltd.) and was on non-invasive ventilator support for 8 days.

Potassium hydroxide (KOH) smear for fungal scraping revealed few fungal spores. Histopathology smear (Fig. 2) from right maxillary sinus showed characteristic broad nonseptate hyphae of Mucor. Wet mount and fungal culture/sensitivity was done from biopsy obtained during debridement. Conservative management was initiated with Amphotericin B and later on with surgical debridement.

Fig. 2
figure 2

Histopathology smear from right maxillary sinus showing broad nonseptate hyphae of Mucor

Imaging findings

The patient underwent high-resolution computed tomography (HRCT) scan of thorax at the time of admission and the findings were consistent with a typical COVID-19 infection (Fig. 3). A CT scan of head was advised on the 3rd day after discharge (17th day from the positive RTPCR) when the patient was readmitted to the hospital for the grayish discharge. The CT head revealed a subtle but critical finding, infiltration of the right retro antral fat plane (Fig. 4) which raised the suspicion of it being something other than just a case of simple sinusitis. Complete opacification of the right maxillary sinus and anterior ethmoidal air cells with internal foci of air without an air fluid level was appreciated. Right ostiomeatal unit (OMU) was blocked (Fig. 5). A small defect was noted in posterior-lateral and inferomedial maxillary wall on right side. Minimal soft tissue thickening was noted in right orbit abutting inferior rectus muscle.

Fig. 3
figure 3

Axial HRCT shows peripherally arranged ground glass opacities with surrounding atelectatic changes in all the lobes of bilateral lungs (red box is one) features typical for COVID-19 with a CT severity score - 17/25

Fig. 4
figure 4

Axial non-contrast CT shows infiltration of the right retroantral fat plane (arrow) indicating invasive disease extending through the posterior wall of the right maxillary sinus

Fig. 5
figure 5

Coronal bone (A) and soft tissue (B) window demonstrating the mucosal thickening in right ethmoidal and bilateral maxillary sinuses (right > left) with collection in right maxillary sinus. A small defect is noted in postero-lateral and inferomedial maxillary wall on right side (arrow) with minimal soft tissue thickening is noted in right orbit abutting inferior rectus muscle (dashed arrow) with a blocked OMU (asterisk)

Two days later, MRI brain (Fig. 6) was performed and showed T1 hypointense and T2 isointense enhancing soft tissue thickening predominantly in the right maxillary and ethmoid sinus extending to involve right pterygoid (Fig. 7) and buccinator muscle, right nasopharynx and pharyngeal mucosal space on right side with intraorbital extension and without any obvious intracranial extension. A small focus of with non-enhancing collection was noted in the right maxillary sinus.

Fig. 6
figure 6

Coronal T2 (A) and T1 FS +Contrast (B) demonstrating the enhancing mucosal thickening in right ethmoidal and bilateral maxillary sinuses with non-enhancing collection in right maxillary sinus (arrowhead). Enhancing soft tissue extension is noted in right orbit abutting inferior rectus muscle (curved arrow) and extending into right nasolacrimal duct (dashed arrow). Laterally, it is extending to involve right buccinator muscle (thin arrow)

Fig. 7
figure 7

T1 sagittal FS + contrast (A) and axial FLAIR (B) study there is enhancement of right medial and lateral pterygoid muscles (red box) and subcutaneous soft tissue component anterior to maxilla on right side. Inflammation and involvement of the right pterygoid muscles (red arrow) and parapharyngeal space below it


While considering the diagnosis of CAROM, we encountered very few reported cases which had described the radiological aspect of the disease [6,7,8]. It is postulated that the SARS-CoV-2 infection may affect CD4+ and CD8+ T cells, with a reduction in the absolute number of lymphocytes and T cells associated with creation of a temporary state of compromised immunity. Orbital involvement results from the spread through the medial orbital wall and nasolacrimal duct as in our case. The fungi invade the adjacent blood vessels causing thrombosis and infarction, as well as dissemination to the brain parenchyma. Fortunately, our patient was diagnosed early and progression to the cerebral form of the disease was prevented.

The more aggressive form of the disease with an early cerebral involvement has been depicted well in a few studies [9] where in retro antral, facial, and orbital fat stranding are the initial indicators of the aggressive course [10, 11].

An effective screening tool (Table 1) was used to screen our patient and it is based on the findings on a non-contrast CT and has shown to predict acute invasive fungal sinusitis with 100% specificity [12]. Our case demonstrated four of the seven features. Much like in our case, the early disease manifestation on CT scan is of mucosal thickening usually without air fluid levels [13].The MRI of the sinuses and orbits in ROM is documented to show three patterns [14] with a majority of the cases showing iso- to hypointense appearance on T2, we appreciated an isointense pattern in our case. The T2 hypointense to isointense appearance may be due to presence of iron and manganese in the fungal elements [15]. As described in previous literature, MRI has proved to be very useful in detection of complications like orbital cellulitis, cavernous sinus thrombosis, and ICA thrombosis [16].

Table 1 The 7 variable CT-based model [12]

Another important radiological finding that has been widely mentioned in literature as relatively specific for the disease is the “Black turbinate sign” [17]. It was from a case report published in 2010 on the basis of two cases of rhino cerebral mucormycosis and it highlighted the MR imaging findings associated with devitalization of the sinonasal mucosa caused by mycotic vascular invasion. Which meant parts of the mucosa would show non enhancement on contrast. Intriguingly, none of the reported CAROM cases characterize the similar appearance or mention it. As in our case, there was no apparent focal devitalization or ischemia of the mucosa which coerces us to think if the sign is really specific for CAROM.


The importance of keeping an eye out for the subtle but critical early imaging findings as described in a known COVID-19 case with symptoms of sinusitis is imperative. Culture and microbiological confirmation takes time usually a few days by using the 7 variable CT model [13] as used in our case can be of help while awaiting the laboratory diagnosis. The typical signs such as the “Black turbinate sign” [17] may not always be seen in the early stages of the disease and suspected individuals should not be dismissed based on the absence of radiologically visible ischemic sinonasal mucosa.

Availability of data and materials

Not applicable



COVID-19-associated rhino-orbital mucormycosis


COVID-19-associated mucormycosis


Rhino-orbital mucormycosis


Reverse transcription polymerase chain reaction


Intensive care unit


High-resolution computed tomography


Magnetic resonance imaging


Computed tomography


Ostiomeatal unit


Internal carotid artery


  1. Hibbett DS, Binder M, Bischoff JF, Blackwell M, Cannon PF, Eriksson OE, Huhndorf S, James T, Kirk PM, Lücking R, Thorsten Lumbsch H, Lutzoni F, Matheny PB, McLaughlin DJ, Powell MJ, Redhead S, Schoch CL, Spatafora JW, Stalpers JA, Vilgalys R, Aime MC, Aptroot A, Bauer R, Begerow D, Benny GL, Castlebury LA, Crous PW, Dai YC, Gams W, Geiser DM, Griffith GW, Gueidan C, Hawksworth DL, Hestmark G, Hosaka K, Humber RA, Hyde KD, Ironside JE, Kõljalg U, Kurtzman CP, Larsson KH, Lichtwardt R, Longcore J, Miądlikowska J, Miller A, Moncalvo JM, Mozley-Standridge S, Oberwinkler F, Parmasto E, Reeb V, Rogers JD, Roux C, Ryvarden L, Sampaio JP, Schüßler A, Sugiyama J, Thorn RG, Tibell L, Untereiner WA, Walker C, Wang Z, Weir A, Weiss M, White MM, Winka K, Yao YJ, Zhang N (2007) A higher-level phylogenetic classification of the Fungi. Mycol Res. 111(5):509–547.

    Article  PubMed  Google Scholar 

  2. Singh AK, Singh R, Joshi SR, Misra A (2021) Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diab Metab Syndr: Clin Res Rev. 2021;15(4):102146

  3. Prakash H, Chakrabarti A (2019) Global epidemiology of mucormycosis. J Fungi 5(1):26.

    CAS  Article  Google Scholar 

  4. Skiada A, Pavleas I, Drogari-Apiranthitou M (2020) Epidemiology and diagnosis of mucormycosis: an update. J Fungi 6(4):265.

    CAS  Article  Google Scholar 

  5. Mehta S, Pandey A (2020) Rhino-orbital mucormycosis associated with COVID-19. Cureus 12:e10726

    PubMed  PubMed Central  Google Scholar 

  6. Mekonnen ZK, Ashraf DC, Jankowski T, Grob SR, Vagefi MR, Kersten RC, Simko JP, Winn BJ (2021) Acute invasive rhino-orbital mucormycosis in a patient with COVID-19-associated acute respiratory distress syndrome. Ophthalmic Plast Reconstr Surg 37(2):e40–e80.

    Article  PubMed  Google Scholar 

  7. Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med. In Press 2021;42:264.e5–264.e8.

  8. Mossa-Basha M, Ilica AT, Maluf F, Karakoç Ö, İzbudak İ, Aygün N (2013 May 1) The many faces of fungal disease of the paranasal sinuses: CT and MRI findings. Diagn Interv Radiol 19(3):195–200.

    Article  PubMed  Google Scholar 

  9. Herrera DA, Dublin AB, Ormsby EL, Aminpour S, Howell LP (2009 Mar) Imaging findings of rhinocerebral mucormycosis. Skull Base. 19(2):117–125.

    Article  PubMed  PubMed Central  Google Scholar 

  10. N, Hmaied E, Oueslati S, Rajhi H, Hamza R, Marrakchi M et al (2005) L’imageriedans la mucormycose rhinocérébrale. J Radiol 86:1017–1020

    Article  Google Scholar 

  11. Silverman CS, Mancuso AA (1998 Feb) Periantral soft-tissue infiltration and its relevance to the early detection of invasive fungal sinusitis: CT and MR findings. AJNR Am J Neuroradiol. 19(2):321–325 PMID: 9504486

  12. Middlebrooks EH, Frost CJ, Jesus ROD, Massini TC, Schmalfuss IM, Mancuso AA (2015) Acute invasive fungal rhinosinusitis: a comprehensive update of CTfindings anddesign of an effective diagnostic imaging model. Am J Neuroradiol 36:1529–1535

    CAS  Article  Google Scholar 

  13. Gamba JL, Woodruff WW, Djang WT, Yeates AE (1986) Craniofacial mucormycosis: assessment with CT. Radiology 160(1):207–212.

    CAS  Article  PubMed  Google Scholar 

  14. Therakathu J, Prabhu S, Irodi A, Sudhakar SV, Yadav VK, Rupa V (2018) Imaging features of rhinocerebral mucormycosis: a study of 43 patients. Egypt J Radiol Nucl Med 49(2):447–452.

    Article  Google Scholar 

  15. Terk MR, Underwood DJ, Zee CS, Colletti PM (1992) MR imaging in rhinocerebral and intracranial mucormycosis with CT and pathologic correlation. Magn Reson Imaging 10(1):81–87.

    CAS  Article  PubMed  Google Scholar 

  16. McDevitt GR, Brantley MJ, Cawthon MA (1989) Rhinocerebral mucormycosis: a case report with magnetic resonance imaging findings. Clin Imaging 13(4):317–320.

    Article  PubMed  Google Scholar 

  17. Safder S, Carpenter JS, Roberts TD, Bailey N (2010) The “black turbinate” sign: an early MR imaging finding of nasal mucormycosis. Am J Neuroradiol 31(4):771–774.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references





Author information

Authors and Affiliations



This study was directed and coordinated by HSS and KKS, HSS as the principal investigator, provided conceptual and technical guidance for all aspects of the project. KKS, SSM, and SP planned and performed the analysis of the MRI and CT images along with help from HSS and KRK. Literature search was suggested and executed by KRK. Design of the study was by SSM and KKS. The manuscript was written by HSS and KKS and commented on by all authors. The laboratory portion was confirmed by CM. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Humsheer Singh Sethi.

Ethics declarations

Ethics approval and consent to participate

Not applicable

Consent for publication

Yes, written consent to publish this information was obtained from study participant.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sethi, H.S., Sen, K.K., Mohanty, S.S. et al. COVID-19-associated rhino-orbital mucormycosis (CAROM)—a case report. Egypt J Radiol Nucl Med 52, 165 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • COVID-19-associated mucormycosis
  • Rhino-orbital mucormycosis
  • COVID-19
  • Black fungus